In this retrospective clinical study the effect of vildagliptin, a DPP4 inhibitor, was investigated on cognitive dysfunction in 60 elderly patients with diabetes with additional diagnosis of mild cognitive impairment (MCI). This evidence concerns the gene DPP4 and diabetes mellitus.